Hepatitis B News and Research

Latest Hepatitis B News and Research

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A new study discusses the development of recombinant vesicular stomatitis virus COVID-19 vaccines.

25 Jul 2022

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.

25 Jul 2022

Study assesses eight de novo genome assembly software tools on viral next-generation sequencing data

A new study compares and assesses eight de novo genome assembly software tools on actual viral next-generation sequencing data.

20 Jul 2022

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

The Centers for Disease Control and Prevention (CDC) has recommended that Novavax's COVID-19 vaccine be used as another primary series option for adults in the United States ages 18 years and older.

20 Jul 2022

Can COVID-19 vaccination cause menstrual bleeding changes?

A recent study examined changes in menstrual bleeding following vaccination against SARS-CoV-2 among ethnically and gender-diverse pre-and postmenopausal women.

20 Jul 2022

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

Carefully designed cocktails of broadly neutralizing antibodies (bNAbs) could help treat HIV while minimizing the risk of the virus escaping treatment, suggests a study published today in eLife.

20 Jul 2022

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

Researchers described the shedding of the monkeypox (MPX) virus (MPXV) in Barcelona city of Spain.

20 Jul 2022

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Researchers reviewed the consequences of infection with sSARS-CoVs on the host DNA damage response.

19 Jul 2022

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Researchers evaluated the activity of nitazoxanide against human coronaviruses (HCoVs).

18 Jul 2022

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

A new analysis of reports from more than 35,000 people offers the most comprehensive assessment so far of menstrual changes experienced by pre- and post-menopausal individuals in the first two weeks after receiving the COVID-19 vaccine.

15 Jul 2022

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

A new mouse model identified by virologists from the University of Pittsburgh might revolutionize development of therapies targeting brain inflammation caused by Rift Valley Fever virus (RVFV).

15 Jul 2022

New liquid biopsy test found to be highly accurate, sensitive for both NASH and liver fibrosis

Researchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases.

14 Jul 2022

SARS-CoV-2 surrogates can survive on refrigerated or frozen meat products for up to 30 days, study finds

SARS-CoV-2 surrogates can survive on meat products in the refrigerator or the freezer, for up to 30 days. Those findings are published in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.

11 Jul 2022

Paxlovid resistance associated with SARS-CoV-2 3CLpro mutations

In a recent study published in the bioRxiv* preprint server, researchers at the Medical University of Innsbruck assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3CLpro mutations responsible for Paxlovid resistance. The 3-chymotrypsin-like protease (3CLPro), or main protease (Mpro), is the main protease found in coronaviruses.

6 Jul 2022

New method helps determine alcohol consumption in fatty liver disease

It is important to know whether patients have non-alcoholic fatty liver disease (NAFLD) or alcohol-related liver disease (ALD), as this distinction plays a key role in treatment and prognosis but cannot be reliably determined by established diagnostic means.

5 Jul 2022

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

The viral replication cycle is crucial for a virus to spread inside the body and cause disease. Focusing on that cycle in the hepatitis A virus (HAV), UNC School of Medicine scientists discovered that replication requires specific interactions between the human protein ZCCHC14 and a group of enzymes called TENT4 poly(A) polymerases.

4 Jul 2022

Impact of SARS-CoV-2 infection on menstrual cycle

Researchers systematically reviewed the impact of COVID-19 on the menstrual cycle.

4 Jul 2022

Machine-learning algorithms can help distinguish acute cholangitis and alcohol-associated hepatitis

Acute cholangitis is a potentially life-threatening bacterial infection that often is associated with gallstones. Symptoms include fever, jaundice, right upper quadrant pain, and elevated liver enzymes.

1 Jul 2022

Crystal structure of a human endogenous reverse transcriptase revealed

The crystal structure of a human endogenous reverse transcriptase has similarities to HIV reverse transcriptase, a well-known tractable drug target, which will help design drugs to treat cancer and other diseases, according to a study co-authored by a Rutgers researcher.

30 Jun 2022

Investigating the prerequisites for developing RNA-based antibiotics

In the fight against the Covid-19 pandemic, mRNA-based vaccines have impressively demonstrated their potential. Using this technology, scientists were able to rapidly develop and bring to market vaccines against SARS-CoV-2 that have been extremely effective at protecting millions of people against severe disease progression of COVID-19 or even death.

29 Jun 2022

Hepatitis B News and Research

Latest Hepatitis B News and Research

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

Study assesses eight de novo genome assembly software tools on viral next-generation sequencing data

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

Can COVID-19 vaccination cause menstrual bleeding changes?

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

New liquid biopsy test found to be highly accurate, sensitive for both NASH and liver fibrosis

SARS-CoV-2 surrogates can survive on refrigerated or frozen meat products for up to 30 days, study finds

Paxlovid resistance associated with SARS-CoV-2 3CLpro mutations

New method helps determine alcohol consumption in fatty liver disease

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

Impact of SARS-CoV-2 infection on menstrual cycle

Machine-learning algorithms can help distinguish acute cholangitis and alcohol-associated hepatitis

Crystal structure of a human endogenous reverse transcriptase revealed

Investigating the prerequisites for developing RNA-based antibiotics

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Hepatitis B News and Research

Latest Hepatitis B News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in